Crestone, Inc.
- Biotech or pharma, therapeutic R&D
Crestone is an anti-infective biotech company that recently announced phase 2 data for CRS3123 in C. difficile gut infections. It is also under investigation for autism, Pitt Hopkins (rare) and GvHD.